Corticosteroid
Triamcinolone, methylprednisolone avoid prednisone’s fracture risk ‘trap’ in lupus
WASHINGTON — Although even low-dose prednisone significantly increases the risk for fracture in systemic lupus erythematosus, there is no increased risk from intramuscular triamcinolone or intravenous methylprednisolone, said a speaker.
Older age, multiple comorbidities frequent in patients starting inhaled COPD therapy
BOSTON — Among adults with COPD starting a new inhaled maintenance treatment, common characteristics included older age and having multiple comorbidities, according to a poster presented at the CHEST Annual Meeting.
54% of pediatric asthma caregivers familiar with oral corticosteroid long-term effects
BOSTON — Among caregivers of children with asthma, only 54% were familiar with oral corticosteroid long-term side effects, according to a poster presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
Adalimumab slashes Behçet’s uveitis relapse rate significantly more than cyclosporine
Adalimumab combined with corticosteroids led to a significantly lower rate of relapse in Behçet’s disease uveitis vs. cyclosporine alongside corticosteroids, according to data published in The Lancet Rheumatology.
Long-Term Management
Air pollution, asthma-related event link weakened by inhaled corticosteroid use
Veterans using inhaled corticosteroids did not face increased odds for an asthma-related health care event after short-term fine particulate matter rises, according to a research letter.
Exacerbation frequency has greater impact on asthma burden than disease severity
Patients who have frequent asthma exacerbations are at greater risks for cumulative doses of corticosteroids, multiple comorbidities and mortality, according to a poster presented at the European Respiratory Society International Congress.
ACR advises against glucocorticoids for interstitial lung disease in systemic sclerosis
New recommendations from the American College of Rheumatology and the American College of Chest Physicians strongly advise against glucocorticoids for interstitial lung disease in systemic sclerosis.